Gene · 369
Papers2,279
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
881 to 900 of 2,279
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Overview of current targeted therapy in gallbladder cancer. | Signal Transduct Target Ther | 2020 | 33028805 | PubTator, text mining | PubMed |
| Integrin Beta 1 Promotes Glioma Cell Proliferation by Negatively Regulating the Notch Pathway. | J Oncol | 2020 | 33014056 | PubTator, text mining | PubMed |
| Analysis of genomic and transcriptomic variations as prognostic signature for lung adenocarcinoma. | BMC Bioinformatics | 2020 | 32998690 | PubTator, text mining | PubMed |
| Extracellular signal-regulated kinases associate with and phosphorylate DHPS to promote cell proliferation. | Oncogenesis | 2020 | 32989218 | PubTator, text mining | PubMed |
| Urinary Exosomal MiRNA-4534 as a Novel Diagnostic Biomarker for Diabetic Kidney Disease. | Front Endocrinol (Lausanne) | 2020 | 32982978 | PubTator, text mining | PubMed |
| Favorable Immune Microenvironment in Patients with EGFR and MAPK Co-Mutations. | Lung Cancer (Auckl) | 2020 | 32982525 | PubTator, text mining | PubMed |
| Residual molecular and behavioral effects of the phenylpyrazole pesticide fipronil in larval zebrafish (Danio rerio) following a pulse embryonic exposure. | Comp Biochem Physiol Part D Genomics Proteomics | 2020 | 32977147 | PubTator, text mining | PubMed |
| Imidazothiazole-based potent inhibitors of V600E-B-RAF kinase with promising anti-melanoma activity: biological and computational studies. | J Enzyme Inhib Med Chem | 2020 | 32962435 | PubTator, text mining | PubMed |
| Integrative network analysis identifies potential targets and drugs for ovarian cancer. | BMC Med Genomics | 2020 | 32958005 | PubTator, text mining | PubMed |
| Genomic characteristics in Chinese non-small cell lung cancer patients and its value in prediction of postoperative prognosis. | Transl Lung Cancer Res | 2020 | 32953497 | PubTator, text mining | PubMed |
| The emergence of targetable MEKanisms in sporadic lymphatic disorders. | EMBO Mol Med | 2020 | 32945117 | PubTator, text mining | PubMed |
| DENR promotes translation reinitiation via ribosome recycling to drive expression of oncogenes including ATF4. | Nat Commun | 2020 | 32938922 | PubTator, text mining | PubMed |
| Histopathological imaging features- versus molecular measurements-based cancer prognosis modeling. | Sci Rep | 2020 | 32929170 | PubTator, text mining | PubMed |
Transcriptomic and Proteomic Analysis of Clear Cell Foci (CCF) in the Human Non-Cirrhotic Liver Identifies Several Differentially Expressed Genes and Proteins with Functions in Cancer Cell Biology and Glycogen Metabolism. | Molecules | 2020 | 32927708 | PubTator, text mining | PubMed |
| Structural basis for the action of the drug trametinib at KSR-bound MEK. | Nature | 2020 | 32927473 | PubTator, text mining | PubMed |
| Silencing ARAF Suppresses the Malignant Phenotypes of Gallbladder Cancer Cells. | Biomed Res Int | 2020 | 32923479 | PubTator, text mining | PubMed |
| Epigenetic stratification of head and neck cancer survivors reveals differences in lycopene levels, alcohol consumption, and methylation of immune regulatory genes. | Clin Epigenetics | 2020 | 32917280 | PubTator, text mining | PubMed |
| Temporal transcriptome analysis suggest modulation of multiple pathways and gene network involved in cell-cell interaction during early phase of high altitude exposure. | PLoS One | 2020 | 32911517 | PubTator, text mining | PubMed |
| Essentiality and Transcriptome-Enriched Pathway Scores Predict Drug-Combination Synergy. | Biology (Basel) | 2020 | 32906805 | PubTator, text mining | PubMed |
| Withanolide Metabolites Inhibit PI3K/AKT and MAPK Pro-Survival Pathways and Induce Apoptosis in Acute Myeloid Leukemia Cells. | Biomedicines | 2020 | 32899914 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/369/papers?page=45